title: Authors' reply to Wardlaw and Berge.
authors: DynaMed, EBSCO Health, EBSCO Information Services, Ipswich, MA 01938, USA balper@EBSCO.com.
authors: Brian S
authors: BS
authors: Alper
authors: DynaMed, EBSCO Health, EBSCO Information Services, Ipswich, MA 01938, USA.
authors: Meghan
authors: M
authors: Malone-Moses
authors: DynaMed, EBSCO Health, EBSCO Information Services, Ipswich, MA 01938, USA.
authors: James S
authors: JS
authors: McLellan
authors: Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
authors: Kameshwar
authors: K
authors: Prasad
authors: Bahrain Branch of the Cochrane Collaboration, Awali, Bahrain.
authors: Eric
authors: E
authors: Manheimer
mesh_terms: D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator